The SAGE Handbook of Drug & Alcohol Studies: Biological ApproachesSAGE, 31 серп. 2016 р. - 578 стор. With contributions from leading international academics across the biological sciences, this handbook takes a critical look at the key contemporary issues and debates in the field. The 31 chapters are divided into four parts: Part I Determination of Substance Misuse Part II PK and PD in Relation to Patterns of Use Part III Detection and Treatment of Drug and Alcohol Use Part IV Controversies and New Approaches This Handbook is an excellent reference text for the growing number of academics, students, scientists and practitioners in the drug and alcohol studies community, and will be a vital resource to the allied professions involved in work-place drug testing, clinical toxicology, and forensic science. |
Зміст
3 | |
Chapter
2 Basic Pharmacokinetics of Substance Misuse | 37 |
The Role of Pharmacogenomics | 57 |
Part
II PK and PD in Relation to Patterns of Use | 61 |
Pharmacokinetics and Pharmacodynamics | 63 |
The Pharma cokinetics of Nicotine and Cotinine | 78 |
A Discussion of Pharmacokinetics and Pharmacodynamics in Those Who Misuse Drugs | 104 |
Pharmacokinetics Pharmacodynamics and Addictive Potential | 123 |
Chapter
18 Biomarkers of Alcohol Misuse | 328 |
Chapter
19 Treatment of Opioid Dependence | 345 |
SewageBased Epidemiology
| 356 |
Part IV
Special Settings | 369 |
Chapter
21 Forensic Toxicology and Death Investigation | 371 |
Chapter
22 Alcoholrelated Offences Alcohol Use Disorders and the Workplace | 377 |
What is the Way Forward for Toxicology and Forensic Research? | 396 |
PART V
Controversies and
New Approaches | 399 |
Pharmacokinetics and Pharmacodynamics | 131 |
Pharmacokinetics | 152 |
A Discussion of Pharmacokinetic and Pharmacodyna mic Effects | 162 |
The Pharmacokinetics and Pharmacodynamics in Misusing Populations | 177 |
The Pharmacokinetics and Pharmacodynamics of Recreational and Medicinal Cannabis | 194 |
The Pharmacokinetics and Pharmacodynamics of Spice and Other Synthetic Cannabinoids
| 213 |
Pharmacokinetic and Pharmacodynamic Parameters
| 249 |
Pharmocokinetics and Pharmacodynamics
| 271 |
Chapter 16 Polysubstance Use
| 283 |
PART III Detection and Treatment of
Drug and Alcohol Use
| 307 |
The Matching of Purposes and Procedures | 309 |
Chapter
24 Intravenous Abuse of Methylphenidate | 401 |
The Way Forward
| 411 |
Chapter 26 Different Approaches to
Setting Limits for Drugs and Alcohol Use When Driving
| 435 |
Chapter
27 Where do Gambling and
Internet Addictions Belong?
The Status of Other Addictions | 446 |
Global Prevalence Health Risks and Propensity for Abuse
| 471 |
Chapter 29 Treating Benzodiazepine Dependence Abstinence or Maintenance?
| 485 |
Pathways into Addiction Diagnosis and Pharmacotherapy | 491 |
Chapter
31 Exploratory Models to Explain Attention Deficit Hyperactivity Disorder and its Association
with Substance Use | 518 |
541 | |
Інші видання - Показати все
The SAGE Handbook of Drug & Alcohol Studies: Biological Approaches Kim Wolff,Jason White,Steven Karch Обмежений попередній перегляд - 2016 |
The SAGE Handbook of Drug & Alcohol Studies: Biological Approaches Kim Wolff,Jason White,Steven Karch Попередній перегляд недоступний - 2016 |
Загальні терміни та фрази
abuse liability activity acute addiction ADHD administration adolescents adults agonists alco alcohol dependence amphetamine analysis associated behaviour Benowitz benzodiazepines blood brain buprenorphine cannabis cathinone chronic cigarette Clin clinical cocaine cognitive comorbid compounds concentrations consumption cotinine detection diazepam disorder dokha dopamine dose drinking driving Drug and Alcohol drugs of abuse effects ence enzymes ethanol ethyl glucuronide European excretion factors Forensic gambling gene genetic Griffiths half-life Health heroin human illicit drug impairment increased individuals interactions intergenic Internet intravenous intron Journal ketamine khat liver MDMA MDPV medication mephedrone metabolism metabolites methadone methamphetamine methylphenidate misuse morphine nicotine opioid oral fluid patients pharmacokinetics Pharmacol Pharmacology plasma polymorphisms population potential prevalence problems Psychiatry psychoactive drugs Psychopharmacology receptor reported risk sample smoking Spice stimulant symptoms synthetic cannabinoids testing therapeutic tion tive tobacco toxicity Toxicology treatment urine users withdrawal